—

DexCom Inc (DXCM) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 62 out of 100 (momentum 67 · quality 79 · valuation 34), as of 2026-11-11.
  • Signal: In a correction — 12.4% off its high — 12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. (as of 2026-11-09)
  • Trend: DexCom Inc trades 4.6% below its 50-day and 8.2% above its 200-day moving average. (as of 2026-11-09)
  • Index seat: HALO Growth 100

DexCom designs and sells continuous glucose monitoring systems for people managing diabetes and metabolic conditions. Its range includes the Dexcom G7 and G6 sensors, the Dexcom ONE+ device meant to replace fingerstick testing, and Stelo, a biosensor for adults with prediabetes or Type 2 diabetes who do not use insulin.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the DXCM overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

In a correction — 12.4% off its high

12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction.

The moving-average stack

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on DXCM?

In a correction — 12.4% off its high — 12.4% below its 52-week high and under its 50-day — a textbook 10-to-20% correction. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is DXCM above its 50-day and 200-day moving averages?

As of 2026-11-09, DexCom Inc trades -4.6% below its 50-day and +8.2% above its 200-day average, with the 20-day -1.7% away.

How far is DXCM from its 52-week high?

12.4% below the 52-week high and 49.8% above the 52-week low, as of 2026-11-09.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.